Trial · NCT00850642
Results by group90
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 90
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| The Numbers of Neutrophils in Induced Sputum-Absolute Neutrophil Count | Placebo | Day -9 to -7 | 5.205 | Standard Deviation 2.8415 | Giga cells per g |
| The Numbers of Neutrophils in Induced Sputum-Absolute Neutrophil Count | GSK2190915 | Day -9 to -7 | 3.096 | Standard Deviation 2.6093 | Giga cells per g |
| The Numbers of Neutrophils in Induced Sputum-Absolute Neutrophil Count | Placebo | Day 1 | 3.142 | Standard Deviation 3.2449 | Giga cells per g |
| The Numbers of Neutrophils in Induced Sputum-Absolute Neutrophil Count | GSK2190915 | Day 1 | 14.667 | Standard Deviation 20.8291 | Giga cells per g |
| The Numbers of Neutrophils in Induced Sputum-Absolute Neutrophil Count | Placebo | Day 12 | 13.534 | Standard Deviation 13.6394 | Giga cells per g |
| The Numbers of Neutrophils in Induced Sputum-Absolute Neutrophil Count | GSK2190915 | Day 12 | 0.396 | Standard Deviation 0.0801 | Giga cells per g |
| The Numbers of Neutrophils in Induced Sputum-Absolute Neutrophil Count | Placebo | Follow-up | 5.359 | Standard Deviation 1.1681 | Giga cells per g |
| The Numbers of Neutrophils in Induced Sputum-Absolute Neutrophil Count | GSK2190915 | Follow-up | 2.995 | Standard Deviation 3.6389 | Giga cells per g |
| Percentage of Neutrophils in Induced Sputum | Placebo | Day -9 to -7 | 84.00 | Standard Deviation 9.469 | Percentage of neutrophils |
| Percentage of Neutrophils in Induced Sputum | GSK2190915 | Day -9 to -7 | 74.88 | Standard Deviation 2.269 | Percentage of neutrophils |
| Percentage of Neutrophils in Induced Sputum | Placebo | Day 1, pre-dose | 68.00 | Standard Deviation 10.607 | Percentage of neutrophils |
| Percentage of Neutrophils in Induced Sputum | GSK2190915 | Day 1, pre-dose | 74.77 | Standard Deviation 18.351 | Percentage of neutrophils |
| Percentage of Neutrophils in Induced Sputum | Placebo | Day 12, 2 hour | 86.30 | Standard Deviation 16.263 | Percentage of neutrophils |
| Percentage of Neutrophils in Induced Sputum | GSK2190915 | Day 12, 2 hour | 56.33 | Standard Deviation 19.732 | Percentage of neutrophils |
| Percentage of Neutrophils in Induced Sputum | Placebo | Follow-up | 65.75 | Standard Deviation 0.071 | Percentage of neutrophils |
| Percentage of Neutrophils in Induced Sputum | GSK2190915 | Follow-up | 78.33 | Standard Deviation 14.640 | Percentage of neutrophils |
| Assessment of FEV1 on Visit 2, 3 and Visit 4 | Placebo | Particpant 1, Day 1, Pre-dose | 2.33 | Liters | |
| Assessment of FEV1 on Visit 2, 3 and Visit 4 | Placebo | Particpant 1, Day 1, 2 hour | 2.55 | Liters | |
| Assessment of FEV1 on Visit 2, 3 and Visit 4 | Placebo | Participant 1, Day 5 to 7/ Visit 3 | 2.56 | Liters | |
| Assessment of FEV1 on Visit 2, 3 and Visit 4 | Placebo | Participant 1, Day 12, Pre-dose | 2.83 | Liters |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00850642/results